嶺東科技大學 |

[NT 42591] Language: 簡体中文

[NT 5635] Back

[NT 59884] Switch To: [NT 5556] Labeled | [NT 5559] MARC Mode | [NT 33762] ISBD

Access to medicines : the interface between patents and human rights : does one size fit all?

[NT 42944] Record Type:	[NT 1579] Language materials, printed : [NT 40817] monographic
[NT 47348] Title Information:	the interface between patents and human rights : does one size fit all?
[NT 47261] Author:	SellinJennifer Anna,
[NT 47351] Place of Publication:	Cambridge, UK
[NT 47263] Published:	Intersentia Publishing;
[NT 47352] Year of Publication:	c2014
[NT 47264] Description:	xvi, 493 p.24 cm.;
[NT 47298] Series:	School of Human Rights research series
[NT 47266] Subject:	Right to health. -
[NT 47266] Subject:	Pharmaceutical policy. -
[NT 47266] Subject:	Patents (International law) -
[NT 47266] Subject:	Medical care, Cost of - Law and legislation -
[NT 47266] Subject:	Human rights. -
[NT 47266] Subject:	Drugs - Patents -
[NT 47265] Notes:	Originally presented as the author's thesis (Ph.D.)--Universiteit Maastricht, 2014
[NT 51398] Summary:	"Millions of people worldwide lack adequate access to medicines, particularly in developing countries where resources are scarce with devastating human, social and economic consequences. The example of HIV/AIDS, for which treatment has advanced so significantly in the last decade that a diagnosis no longer necessarily brings with it a death sentence, highlights the importance of ensuring that essential medicines are affordable and accessible to all. This book focuses on one aspect of access to medicines: the affordability of essential medicines, and its connection to human rights and patents. The argument often made is that patent protection for medicines results in higher prices which negatively impacts access. Patients having no or inadequate access to affordable medicines endangers the full realisation of human rights, particularly the right to health. This book investigates this issue from a legal perspective, taking both an international and domestic angle. This study examines the interface of access to affordable medicines and patent protection from the perspective of international human rights law and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) within the framework of the World Trade Organisation. The essential question posed by this book is whether access to medicines and patent protection conflict or coexist. The discussion is deepened by including a developing country approach. Three country studies have been conducted, on South Africa, India and Uganda. These aim to provide a concrete insight into whether these countries recognise and acknowledge the interplay between patents and human rights with respect to access to medicines. Secondly these studies examine whether TRIPS leaves sufficient freedom for (developing) states to adopt a patent system suited to their domestic needs, enabling them to strike a fair balance between access to medicines and patent protection for medicines. In other words: does one size
[NT 50961] ISBN:	978-1-78068-247-1pbk.
[NT 50961] ISBN:	1-78068-247-6pbk.

Access to medicines : the interface between patents and human rights : does one size fit all?
Sellin, Jennifer Anna

Access to medicines : the interface between patents and human rights : does one size fit all? / Jennifer Anna Sellin - Cambridge, UK : Intersentia Publishing, c2014. - xvi, 493 p. ; 24 cm.. - (School of Human Rights research series ; v. 64).
Originally presented as the author's thesis (Ph.D.)--Universiteit Maastricht, 2014.
Includes bibliographical references (p. 461-490).
ISBN 978-1-78068-247-1ISBN 1-78068-247-6
Right to health.Pharmaceutical policy.Patents (International law)Medical care, Cost ofHuman rights.Drugs -- Law and legislation -- Patents

Access to medicines : the interface between patents and human rights : does one size fit all?
LDR:02773cam0 2200217 450 001 309768
005 20141223103551.0
010 1 $a 978-1-78068-247-1 $b pbk. $d NT$2814
010 1 $a 1-78068-247-6 $b pbk. $d NT$2814
100 $a 20151112d2014 m y0engy01 b
101 0 $a eng
102 $a gb
105 $a y a 000yy
200 1 $a Access to medicines $e the interface between patents and human rights : does one size fit all? $f Jennifer Anna Sellin
210 $a Cambridge, UK $d c2014 $c Intersentia Publishing
215 1 $a xvi, 493 p. $d 24 cm.
225 0 # $a School of Human Rights research series $v v. 64
300 $a Originally presented as the author's thesis (Ph.D.)--Universiteit Maastricht, 2014
320 $a Includes bibliographical references (p. 461-490)
330 $a "Millions of people worldwide lack adequate access to medicines, particularly in developing countries where resources are scarce with devastating human, social and economic consequences. The example of HIV/AIDS, for which treatment has advanced so significantly in the last decade that a diagnosis no longer necessarily brings with it a death sentence, highlights the importance of ensuring that essential medicines are affordable and accessible to all. This book focuses on one aspect of access to medicines: the affordability of essential medicines, and its connection to human rights and patents. The argument often made is that patent protection for medicines results in higher prices which negatively impacts access. Patients having no or inadequate access to affordable medicines endangers the full realisation of human rights, particularly the right to health. This book investigates this issue from a legal perspective, taking both an international and domestic angle. This study examines the interface of access to affordable medicines and patent protection from the perspective of international human rights law and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) within the framework of the World Trade Organisation. The essential question posed by this book is whether access to medicines and patent protection conflict or coexist. The discussion is deepened by including a developing country approach. Three country studies have been conducted, on South Africa, India and Uganda. These aim to provide a concrete insight into whether these countries recognise and acknowledge the interplay between patents and human rights with respect to access to medicines. Secondly these studies examine whether TRIPS leaves sufficient freedom for (developing) states to adopt a patent system suited to their domestic needs, enabling them to strike a fair balance between access to medicines and patent protection for medicines. In other words: does one size
606 # $a Right to health. $2 lc $3 275733
606 # $a Pharmaceutical policy. $2 lc $3 276054
606 # $a Patents (International law) $2 lc $3 268226
606 # $a Medical care, Cost of $x Law and legislation $2 lc $3 369910
606 # $a Human rights. $3 161810
606 # $a Drugs $x Patents $2 lc $3 271460
676 $a 323
700 1 $a Sellin $b Jennifer Anna $3 369909
801 0 $a tw $b 嶺東科技大學圖書館